2019
Chapter 9 Cardiac Sarcoidosis Questions for the Clinician
Varghese M, Shahab Z, Miller E. Chapter 9 Cardiac Sarcoidosis Questions for the Clinician. 2019, 105-113. DOI: 10.1016/b978-0-323-54429-0.00009-4.ChaptersCardiac sarcoidosisMagnetic resonance imagingImplantable cardiac defibrillator placementManagement of CSTreatment of CSDiagnosis of CSFluorodeoxyglucose positron emission tomographyCardiac magnetic resonance imagingNuances of treatmentUse of immunosuppressionPositron emission tomographySymptom reviewDefibrillator placementDiagnostic consensusMultiple guidelinesMultidisciplinary teamResonance imagingEmission tomographySelect groupDiagnosisControversial areasElectrocardiogramFurther testingTreatmentImmunosuppression
2016
The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis
Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis. Journal Of Nuclear Cardiology 2016, 24: 413-424. PMID: 27457527, DOI: 10.1007/s12350-016-0490-7.Peer-Reviewed Original ResearchConceptsFDG PET/CTPET/CTFDG uptakeCardiac sarcoidosisFDG PET/CT studiesPET/CT studiesImmunosuppressive treatmentCardiac inflammationPartial responseComplete resolutionImproved outcomesSUV thresholdImmunosuppressionFDG responseCT studiesPatientsCTSarcoidosisFurther studiesQuantitative changesUptakeResponseInflammationSUVmaxCMV